Valuation: Medtide Inc.

Market Cap 2.83B 3.28B 418M 365M 337M 311M 585M 40.23B 598M 4.03B 1.58B 19.71B 1.57B 1.53B 67.83B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 1.93B 2.24B 285M 249M 230M 212M 400M 27.47B 409M 2.75B 1.08B 13.46B 1.07B 1.05B 46.32B EV / Sales 2026 *
2.83x
EV / Sales 2027 * 2x
Free-Float
28.85%
Yield 2026 *
-
Yield 2027 * -
1 day-3.43%
1 week-2.94%
Current month+4.62%
1 month+3.12%
3 months+3.77%
6 months-19.06%
Current year-24.21%
1 week 22.64
Extreme 22.64
25
1 month 20.24
Extreme 20.24
25
Current year 19
Extreme 19
30.46
1 year 19
Extreme 19
41.72
3 years 19
Extreme 19
41.72
5 years 19
Extreme 19
41.72
10 years 19
Extreme 19
41.72
Manager TitleAgeSince
Chief Executive Officer 58 2020-06-10
Director of Finance/CFO 53 2020-09-30
Investor Relations Contact 50 2023-08-31
Director TitleAgeSince
Chairman 58 2020-06-10
Director/Board Member 51 2022-01-26
Director/Board Member 63 2022-01-26
Date Insider Type Main position Quantity % Market Cap.
3/9/26 Other

Chief Executive Officer

68,201,112 48.0967%
3/9/26 Other

Director

68,201,112 48.0967%
3/9/26 Other

Director

68,201,112 48.0967%
Change 5-day change 1-year change 3-year change Capi.($)
-3.43%-2.94%-32.06% - 418M
+3.90%-0.39%+376.72%+599.59% 39.58B
-1.70%+4.46%+7.46%+57.67% 34.69B
-2.01%-0.76%+26.35%-6.83% 34.42B
+0.06%+0.34%+2.32%+29.30% 27.11B
+0.46%-3.49% - - 16.21B
-0.04%-0.09%+68.48%+117.39% 15.36B
+1.12%+1.91%+15.90%+19.65% 14.05B
0.00%+1.36%+15.74%-30.62% 13.02B
-0.08%-3.01%+1,271.69%+649.69% 11.76B
Average -0.17%-0.26%+194.73%+179.48% 20.66B
Weighted average by Cap. +0.23%+0.35%+170.98%+187.42%

Financials

2026 *2027 *
Net sales 684M 791M 101M 88.2M 81.39M 75.02M 141M 9.72B 145M 973M 383M 4.76B 379M 371M 16.39B 876M 1.01B 129M 113M 104M 96.03M 181M 12.44B 185M 1.25B 490M 6.09B 485M 475M 20.98B
Net income - -
Net Debt -898M -1.04B -133M -116M -107M -98.49M -186M -12.76B -190M -1.28B -502M -6.25B -498M -487M -21.51B -1.08B -1.25B -159M -139M -129M -119M -223M -15.36B -228M -1.54B -605M -7.52B -599M -586M -25.89B
Logo Medtide Inc.
Medtide Inc is a China-based company mainly engaged in the contract research, development and manufacturing of peptide. The Company mainly provides contract research organization (CRO) services, namely peptide new chemical entity (NCE) discovery synthesis, contract development and manufacturing organization (CDMO) services, namely peptide chemistry, manufacturing, and control (CMC) development and commercial manufacturing. The Company's services primarily focus on providing customers with active pharmaceutical ingredients (APIs) rather than drug products. The Company also provides customers with peptide drug development, production, and CMC filing support services. The Company mainly operates its business in the domestic market and overseas markets.
Employees
566
Date Price Change Volume
26-07-17 HK$23.10 -3.43% 76,600
26-07-16 HK$23.92 -1.97% 115,300
26-07-15 HK$24.40 +1.24% 108,000
26-07-14 HK$24.10 +0.42% 104,900
26-07-13 HK$24.00 +0.84% 84,800
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
19.97CNY
Average target price
25.19CNY
Spread / Average Target
+26.14%

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 3880 Stock